Brief: Anteris Technologies Announces A$35 Mln Capital Raise
Feb 9 (Reuters) - Anteris Technologies Ltd AVR.AX :
* A$35M CAPITAL RAISE
* PLACEMENT AT AN ISSUE PRICE OF A$24.00 PER NEW SHARE
* PROCEEDS WILL BE USED PRIMARILY FOR CLINICAL DEVELOPMENT
OF
DURAVRTM, AMONG OTHERS
Source text for Eikon: ID:nASX4BpHFX
Further company coverage: AVR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anteris Technologies
See all newsBrief: Anteris Technologies Global Corp Gets French Regulatory Clearance For Duravr Paradigm Global Pivotal Trial
Anteris Technologies up as brokerages initiate coverage post-research quiet period
Brief: Anteris Technologies Says Aggregate Gross Proceeds From Offering Was $88.8 Mln
Anteris Technologies slides in Nasdaq debut after $89 mln US IPO
Brief: Anteris Technologies Prices 14.8 Mln Shares At $6.00 Per Share for U.S. IPO